New mutations were found in OR1B1 (GPCR signaling pathway) in adenoma evolution, and LAMA1 (PI3K-Akt signaling pathway) and ADCY3 (FGFR signaling pathway) in CRC evolution. This evidence concerns the gene LAMA1 and colorectal carcinoma.